Effects in Oxygenation and Hypoxic Pulmonary Vasoconstriction in ARDS Secondary to SARS-CoV2

NCT04998253 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Hypoxic Pulmonary Vasoconstriction
Hypoxemia
Acute Respiratory Distress Syndrome
SARS-CoV-2 Acute Respiratory Disease

Interventions

DRUG: Effects in oxygenation and hypoxic pulmonary vasoconstriction

Sponsor

Unidad Temporal COVID-19 en Centro Citibanamex